Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

06/05/2022 22:15

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

05/05/2022 20:15

UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

05/05/2022 14:30

Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

03/05/2022 14:30

Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

27/04/2022 16:20

Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

20/04/2022 14:30

Jaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

15/04/2022 22:15

Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

06/04/2022 14:30

Jaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

05/04/2022 14:30

Jaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

31/03/2022 12:30

Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets

Voir tous les communiqués de Jaguar Health, Inc.

«
1
2
3
4
5
»